The Middle East & Africa Market size for veterinary diagnostics is expected to grow at a CAGR of 6.88% from 2023 to 2028 and be worth USD 610 million by 2028 from USD 440 million in 2023 due to the increase in the number of foodborne diseases affecting the animals.
Veterinary Diagnostics provides tools for effectively testing animal health conditions to undertake preventative or remedial measures. Several diseases in animals are determined and recognized by examinations through tests with veterinary diagnostics. These tests are performed by collecting feces, blood, and serum.
The need to perform various tests has increased gradually. In turn, the market for Molecular diagnostics is expected to grow at a higher than that of Immunodiagnostics due to the broad scope it provides over the likes of immunodiagnostics. An increase in the purchase and usage of various diagnostic instruments utilized in veterinary practices, in-clinic diagnostic procedures, high-income households that keep pets, and regularly visit veterinary laboratories are propelling the growth of this market.
However, increasing the adoption of vegetarian food due to changing food habits, the economic downturn, the increased risk of obesity, exposure to global cuisines, and other diseases affect the growth.
For instance, lateral flow and other rapid tests are used in veterinary medicine to test commercial livestock (large animals - cows, poultry, sheep, pigs, etc.) and household pets (cats, dogs, etc.) to check for the presence of a variety of medical conditions caused by bacteria, viruses, allergies, and fertility issues. Food animal diagnostics assist in livestock and production animal preventive care and complement other vaccination and selective breeding measures. Veterinary diagnostic products are as complex as they are challenging to manufacture. Many of the tests the veterinarian uses to diagnose disease require highly specialized instruments or equipment. In other cases, specific training is necessary for the technicians performing the tests.
This research report on the MEA veterinary diagnostics market has been segmented and sub-segmented into the following categories:
Regionally, the Middle East and African market is expected to grow as the demand for cost-active veterinary market diagnostic equipment is high. The rise in the occurrence of zoonotic diseases and their linkage to the human chain effecting by these diseases created an alert for veterinary examinations and the diagnostic market. The growing demand for pet adoption and insurance drives market levels.
The Middle East and African countries have the highest animal density, proving market potential for veterinary diagnosis. In African countries, as per research, families in this region are showcasing interest in having pets included. As the adoption of pets is increasing, market growth increases parallel. The compensation for veterinary doctors and their annual income level is considerably high than in any other region. Also, the number of veterinary surgeons every year are increasing, and thus the treatments, medical centers, and examination staff are also on-demand. Government funding in recent years for African countries for improvising veterinary diagnostics and pharmaceutical markets is observed. For instance, in Uganda, Nigeria, and Ethiopia, Zoetis, in the year 2018, established sustainable veterinary diagnostic networks and animal health infrastructure funded by a USD 14.4 Million grant from Bill Melinda Gates Foundation.
Key companies leading the MEA Veterinary Diagnostics Market profiled in this report are VCA Inc., Heska Corporation, Abaxis Inc., VIRBAC, IDEXX Laboratories Inc., Life Technologies Corporation, Bio-Rad Laboratories Inc., Prionics AG, and Pfizer, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]